We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Vertex Plans IND for Implantable Islet Cell Device for Type 1 Diabetes
Vertex Plans IND for Implantable Islet Cell Device for Type 1 Diabetes
Vertex Pharmaceuticals will submit an Investigational New Device (IND) application next year for a drug/device combination that delivers insulin-producing, lab-created islet cells in a membrane packet to protect them from the body’s immune system.